BrainStorm Cell Therapeutics
phase trial study design designed to exclude slow | BrainStorm Cell Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
5 of 15
Related slides by other companies
ATAI
Investor Conference
May 2023
phase trial design randomized week study of and placebo in patients with | ATAI
Fusion Pharmaceuticals
Investor Presentation
January 2024
fusion aligns with on potential registrational pathway a | Fusion Pharmaceuticals
Anebulo Pharmaceuticals
Investor Day
September 2022
phase proof of concept trial design | Anebulo Pharmaceuticals
Compass Therapeutics
Investor Presentation
May 2023
phase study design compass | Compass Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights